JP2017537056A5 - - Google Patents

Download PDF

Info

Publication number
JP2017537056A5
JP2017537056A5 JP2017515897A JP2017515897A JP2017537056A5 JP 2017537056 A5 JP2017537056 A5 JP 2017537056A5 JP 2017515897 A JP2017515897 A JP 2017515897A JP 2017515897 A JP2017515897 A JP 2017515897A JP 2017537056 A5 JP2017537056 A5 JP 2017537056A5
Authority
JP
Japan
Prior art keywords
methyl
substituted
pyrazol
compound according
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017515897A
Other languages
English (en)
Japanese (ja)
Other versions
JP6669734B2 (ja
JP2017537056A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/074923 external-priority patent/WO2016066663A1/en
Publication of JP2017537056A publication Critical patent/JP2017537056A/ja
Publication of JP2017537056A5 publication Critical patent/JP2017537056A5/ja
Application granted granted Critical
Publication of JP6669734B2 publication Critical patent/JP6669734B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017515897A 2014-10-31 2015-10-28 ピラゾリル−3,4−ジドヒドロキノリン−2−オン・アルドステロン合成酵素阻害剤 Active JP6669734B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2014/090064 2014-10-31
CN2014090064 2014-10-31
PCT/EP2015/074923 WO2016066663A1 (en) 2014-10-31 2015-10-28 Pyrazolyl-3,4-dihydroquinolin-2-one aldosterone synthase inhibitors

Publications (3)

Publication Number Publication Date
JP2017537056A JP2017537056A (ja) 2017-12-14
JP2017537056A5 true JP2017537056A5 (enExample) 2018-12-06
JP6669734B2 JP6669734B2 (ja) 2020-03-18

Family

ID=54356342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017515897A Active JP6669734B2 (ja) 2014-10-31 2015-10-28 ピラゾリル−3,4−ジドヒドロキノリン−2−オン・アルドステロン合成酵素阻害剤

Country Status (5)

Country Link
US (1) US9796702B2 (enExample)
EP (1) EP3212631B1 (enExample)
JP (1) JP6669734B2 (enExample)
CN (1) CN106660998B (enExample)
WO (1) WO2016066663A1 (enExample)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739338A (en) * 1996-11-05 1998-04-14 Allergan N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
CA2846785C (en) * 2011-09-15 2020-09-22 F. Hoffmann-La Roche Ag New dihydroquinoline-2-one derivatives
US9353081B2 (en) * 2011-09-23 2016-05-31 Hoffmann-La Roche Inc. Bicyclic dihydroquinoline-2-one derivatives
WO2014135561A1 (en) * 2013-03-08 2014-09-12 F. Hoffmann-La Roche Ag New dihydroquinoline-2-one derivatives as aldosterone synthase (cyp1 1 b2 or cyp1 1 b1 ) inhibitors
KR20150119207A (ko) * 2013-03-14 2015-10-23 에프. 호프만-라 로슈 아게 알도스테론 신타제 억제제로서 사용하기 위한 다이하이드로퀴놀린-2-온 유도체

Similar Documents

Publication Publication Date Title
JP2014507464A5 (enExample)
JP2010525023A5 (enExample)
JP2013510125A5 (enExample)
JP2010508338A5 (enExample)
JP2014513110A5 (enExample)
JP2018515555A5 (enExample)
JP2017502940A5 (enExample)
JP2016525076A5 (enExample)
JP2018532788A5 (enExample)
JP2016535772A5 (enExample)
RU2017127135A (ru) Терапевтическое средство против рака желчных протоков
JP2009533410A5 (enExample)
JP2018502877A5 (enExample)
JP2009536197A5 (enExample)
JPWO2021211864A5 (enExample)
JP2016513660A5 (enExample)
JP2017533968A5 (enExample)
JP2013525356A5 (enExample)
JP2015501799A5 (enExample)
JP2018527295A5 (enExample)
JP2014504646A5 (enExample)
RU2018131766A (ru) 6-гетероциклил-4-морфолин-4-илпиридин-2-оны, пригодные для лечения рака и диабета
JP2013531070A5 (enExample)
JP2013542267A5 (enExample)
JP2019510794A5 (enExample)